Date Title Description PDF
02 Mar 2021 On business and financial situation The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download
24 Feb 2021 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
27 Nov 2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia Download
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
27 Jul 2020 About corporate governance The Company informs about the agreements adopted by the Board of Directors.   Download
27 Jul 2020 On business and financial situation ROVI releases the 2020 First Half Results presentation Download
02 Jul 2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the second quarter of 2020 Download
13 May 2020 On business and financial situation ROVI releases the presentation related to the first quarter 2020 financial results Download
13 May 2020 Interim Management Report The company releases the press release related to the 2020 first quarter financial results Download

Pages

Date Title Description PDF
09 Oct 2015 Otros sobre operaciones corporativas Download
08 Oct 2015 Otros sobre operaciones corporativas Download
30 Jul 2015 Información sobre resultados (2) Download
30 Jul 2015 Información sobre resultados Download
30 Jun 2015 Información sobre dividendos Download

Pages